RecruitingNot ApplicableNCT07126522

Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors

Advancing Survivorship Support Through Virtual Health Equity Resources for Breast Cancer Responsive Education (HERCaRE)

Sponsor

Mayo Clinic

Enrollment

200 participants

Start Date

Jul 18, 2025

Study Type

INTERVENTIONAL

Conditions

Breast Carcinoma

Summary

This clinical trial studies how well a virtual support platform, the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) application (app), works in improving survivorship among Black survivors of breast cancer. The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment. This trial may help improve how digital health interventions can enhance survivorship support and access to resources.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a smartphone app called HERCaRE designed to help Black women who have finished breast cancer treatment feel better supported during survivorship — the period after active treatment ends. **You may be eligible if...** - You are 18 or older - You self-identify as a Black or African American woman - You have a history of breast cancer and finished active treatment (surgery, chemo, or radiation) at least one month ago - You are on long-term hormone therapy (that counts too) - You live in the Mayo Clinic Florida area - You have or can access a smartphone or tablet **You may NOT be eligible if...** - You have never had breast cancer - You are unable to give verbal consent - You are not comfortable using a smartphone app independently Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.